(Q73903596)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Induction of 'blocking' IgG antibodies during immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

2

S R Durham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

P A Wachholz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1171-1174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

Long-term clinical efficacy of grass-pollen immunotherapy

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Ragweed immunotherapy in adult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Molecular mechanisms of endotoxin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Inhibition of IgE-induced activation of human mast cells by IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01765.X

10.1046/J.1365-2222.2003.01765.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956735%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference